Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Breast Cancer × Electroporation × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pancreatic Neoplasms 16 Prostatic Neoplasms 9 Carcinoma, Hepatocellular 7 Liver Neoplasms 6 Neoplasm Metastasis 3 Head and Neck Neoplasms 3 Colorectal Neoplasms 3 Stomach Neoplasms 2 Neoplasms 2 Melanoma 2 Lymphatic Metastasis 2 Lung Neoplasms 2 Locally Advanced Pancreatic Cancer 2 Carcinoma, Renal Cell 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Ureteral Neoplasms 1 Unresectable Pancreatic Cancer 1 Triple Negative Breast Neoplasms 1 Squamous Intraepithelial Lesions 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumor Including Thyroid, Bone, Liver, Pancreas 1 Small Cell Lung Carcinoma 1 Skin Neoplasms 1 Rectal Neoplasms 1 Pancreatic Ductal Adenocarcinoma 1 Pancreatic Adenocarcinoma Resectable 1 Liver, Cancer of, Non-Resectable 1 Liver Metastasis Colon Cancer 1 Liver Diseases 1

Interventions

Fulvestrant 16 Letrozole 8 Anastrozole 7 Capecitabine 5 olaparib 4 Docetaxel 4 pyrotinib 3 palbociclib 3 Vinorelbine 3 Goserelin 3 Aromatase Inhibitors 3 trastuzumab deruxtecan 2 sacituzumab govitecan 2 exemestane 2 dalpiciclib 2 Trastuzumab 2 Paclitaxel 2 FCN-437c 2 Dasatinib 2 Alpelisib 2 vandetanib 1 talazoparib 1 sonidegib 1 neratinib 1 liposomal doxorubicin 1 irinotecan sucrosofate 1 eribulin 1 entinostat 1 elacestrant 1 disitamab vedotin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03240224 2019-01-25

Bioinformation Therapy for Breast Cancer

Fuda Cancer Hospital, Guangzhou

Phase 2/3 Completed

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡